戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 692作成日:2026年10月23日

tert-Butyl piperazine-1-carboxylate → Tert-butyl 4-(3-chloro-4-cyanophenyl)piperazine-1-carboxylate

https://huagongshe.com/ja/reaction/692

反応式

関与物質

役割名称HCID仕込み量
反応物tert-Butyl piperazine-1-carboxylateHCID 143452—
反応物4-Bromo-2-chlorobenzonitrileHCID 7010420—
試薬Cesium carbonateHCID 10796—
触媒Binap, (A+-)-HCID 634876—
触媒Palladium (II) acetateHCID 4144353—
溶媒TolueneHCID 1140—
生成物Tert-butyl 4-(3-chloro-4-cyanophenyl)piperazine-1-carboxylateHCID 5648197747.09%

反応条件

温度80 °C

反応手順

In a 250 mL round-bottomed dried flask , diacetoxypalladium (0.036 g, 0.16 mmol) was treated with 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (0.195 g, 0.31 mmol) under nitrogen in toluene (35 mL). The reaction was heated to 80 °C and was stirred for 10 min. To the flask was then added tert-butyl piperazine-1-carboxylate (0.602 g, 3.23 mmol), cesium carbonate (0.527 g, 1.62 mmol), potassium carbonate (0.447 g, 3.23 mmol) and 1,4,7,10,13,16-hexaoxacyclooctadecane (0.085 g, 0.32 mmol). The reaction was then treated with 4-bromo-2-chlorobenzonitrile (0.7 g, 3.23 mmol) and was allowed to stir at 80°C for 5 h. The mixture was then filtered over celite and celite was washed with heptanes. The mixture was condensed under reduced pressure and the crude material was purified on preparative HPLC MS using the short high pH shallow gradient method (Mobile phase: 50-70% B; A: H2O with 10 mM NH4CO3 and 0.375% NH4OH v/v, B: CH3CN, 10 min run) on XBridge Prep C18 OBD, 30x50 mm, 5 mm, Waters reverse phase column, to afford tert-butyl 4-(3-chloro-4-cyanophenyl)piperazine-1-carboxylate (0.490 g, 47.1 %) as a white solid.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-80eaa5d6e27d4cf78d75715b3843cadc
出典メモ750 AstraZeneca ELN dataset